Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | TYR | P14679 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.37 |
| ▸ | ESRRG | P62508 | 1/20 | 0.37 |
| ▸ | MLYCD | O95822 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 4/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20599272 | 0.84 | EGFR (0.36) | LMNATYRCYP2D6TSHRKCNH2 | |
| SCHEMBL6842544 | 0.82 | NPC1 (0.40) | LMNAMLYCDMAPTPOLBMEN1 | |
| SCHEMBL23172938 | 0.82 | NR1H2 (0.36) | LMNACYP2D6KCNH2MAPTMEN1 | |
| SCHEMBL6243535 | 0.82 | MAPT (0.44) | LMNACYP2D6TSHRKCNH2MAPT | |
| SCHEMBL14112771 | 0.82 | L3MBTL1 (0.44) | LMNATYRTSHRKCNH2NR1H4 | |
| SCHEMBL14432466 | 0.81 | TSHR (0.41) | LMNATYRCYP2D6TSHRKCNH2 | |
| Hydrochloric Acid SCHEMBL8038931 | 0.79 | MAPT (0.43) | LMNACYP2D6TSHRMAPTPOLB | |
| SCHEMBL43496 | 0.79 | GABRA1 (0.43) | LMNACYP2D6MAPTPOLBMEN1 | |
| SCHEMBL23172939 | 0.79 | TSHR (0.39) | LMNATYRCYP2D6TSHRKCNH2 | |
| SCHEMBL13409185 | 0.79 | TSHR (0.39) | LMNATYRCYP2D6TSHRKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 547 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119552300-A | Method for realizing anti-caking of acrylic resin powder by chemical doping method | 博立尔化工（扬州）有限公司 | 2025-03-04 | — | — | CN | claimed |
| US-20260144714-A1 | KIT FOR PREPARING CURABLE COMPOSITION FOR DENTAL MATERIAL, CURABLE COMPOSITION FOR DENTAL MATERIAL, AND DENTAL MATERIAL | MITSUI CHEMICALS, INC. (JP) | 2026-05-28 | — | — | US | disclosed |
| US-12622847-B2 | Organosilicon compound and dental composition containing same | KURARAY NORITAKE DENTAL INC. (JP) | 2026-05-12 | — | — | US | disclosed |
| US-20260124121-A1 | POLYMERIZABLE DENTAL COMPOSITION | TROETSCHLER TOBIAS (DE) | 2026-05-07 | — | — | US | disclosed |
| EP-3861977-B1 | (METH)ACRYLATE, MONOMER COMPOSITION, MOLDED BODY, COMPOSITION FOR DENTAL MATERIAL, AND DENTAL MATERIAL | MITSUI CHEMICALS INC (JP) | 2026-05-06 | — | — | EP | disclosed |
| EP-4736833-A1 | POLYMERIZABLE DENTAL COMPOSITION | DENTSPLY SIRONA Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-4725470-A1 | CURABLE DENTAL COMPOSITION | Kuraray Noritake Dental Inc. (JP) | 2026-04-15 | — | — | EP | disclosed |
| US-12564543-B2 | Dental composition | KURARAY NORITAKE DENTAL INC. (JP) | 2026-03-03 | — | — | US | disclosed |
| US-12527725-B2 | Solvent-free dental adhesive composition | KURARAY NORITAKE DENTAL INC. (JP) | 2026-01-20 | — | — | US | disclosed |
| US-12478562-B2 | Dental restoration material composition | KURARAY NORITAKE DENTAL INC. (JP) | 2025-11-25 | — | — | US | disclosed |
| EP-0980682-A1 | Bonding compositions for dental use | KURARAY CO., LTD. (JP) | 2000-02-23 | — | — | EP | disclosed |
| EP-0948955-A1 | POLYMERIZABLE DENTAL COMPOSITION | KURARAY CO., LTD. (JP) | 1999-10-13 | — | — | EP | disclosed |
| EP-0160872-B1 | PROCESS FOR TREATING CELLULOSIC FIBROUS MATERIALS | BAYER AG (DE) | 1988-11-02 | — | — | EP | disclosed |
| EP-0074564-B1 | USE OF 3,4-DISUBSTITUTED ANILINE AS AN ACCELERATOR FOR AN UNSATURATED POLYESTER RESIN | BAYER AG (DE) | 1987-04-22 | — | — | EP | disclosed |
| US-4629468-A | Process for treating cellulosic fibre material | BAYER AKTIENGESELLSCHAFT (DE) | 1986-12-16 | — | — | US | disclosed |
| EP-0160872-A2 | Process for treating cellulosic fibrous materials | BAYER AG (DE) | 1985-11-13 | — | — | EP | disclosed |
| EP-0057398-B1 | PROCESS FOR THE POST-TREATMENT OF DYED, SHRINK-PROOFED FIBROUS MATERIAL | BAYER AG (DE) | 1984-06-13 | — | — | EP | disclosed |
| EP-0017151-B1 | COLD CURING MATERIALS FOR DENTAL PURPOSES WITH POLYMERISATION-ACTIVE SULFONES | BAYER AG (DE) | 1984-02-15 | — | — | EP | disclosed |
| EP-0057398-A2 | Process for the post-treatment of dyed, shrink-proofed fibrous material | BAYER AG (DE) | 1982-08-11 | — | — | EP | disclosed |
| EP-0017151-A2 | Cold curing materials for dental purposes with polymerisation-active sulfones | BAYER AG (DE) | 1980-10-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12527725-B2 | Solvent-free dental adhesive composition | CDH1, ITGA1, ITGB8 | LMNA 2380/4885TYR 3701/4885CYP2D6 3767/4885 |
| US-20260144714-A1 | KIT FOR PREPARING CURABLE COMPOSITION FOR DENTAL MATERIAL, CURABLE COMPOSITION FOR DENTAL MATERIAL, AND DENTAL MATERIAL | CAD, KIT, ILK | LMNA 1719/4885TYR 1258/4885CYP2D6 4552/4885 |
| US-12564543-B2 | Dental composition | CAD, ARCN1, MAT1A | LMNA 1972/4885TYR 3883/4885CYP2D6 4391/4885 |
| US-12478562-B2 | Dental restoration material composition | CAD, MAT2B, RER1 | LMNA 2860/4885TYR 3646/4885CYP2D6 1800/4885 |
| US-12622847-B2 | Organosilicon compound and dental composition containing same | MSL1, ITGA1, ITGAL | LMNA 2975/4885TYR 3546/4885CYP2D6 1073/4885 |
| US-20260124121-A1 | POLYMERIZABLE DENTAL COMPOSITION | F12, RAD51, PFN1 | LMNA 1130/4885TYR 4168/4885CYP2D6 1980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.